K H Yoon
Overview
Explore the profile of K H Yoon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
947
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lim L, Lau E, Kong A, Fu A, Lau V, Jia W, et al.
Lancet Reg Health West Pac
. 2023 Feb;
32:100663.
PMID: 36785858
Background: In Asia, diabetes-associated death due to cardiorenal diseases were 2-3 times higher in women than men which might be due to gender disparity in quality of care and health...
2.
Cheung J, Lau E, Tsui C, Siu E, Tse N, Hui N, et al.
BMC Med
. 2022 Jul;
20(1):249.
PMID: 35831899
Background: Family history (FamH) of type 2 diabetes might indicate shared genotypes, environments, and/or behaviors. We hypothesize that FamH interacts with unhealthy behaviors to increase the risk of early onset...
3.
Noh J, Kyiung H, Yoon K, Roh Y
Acta Orthop Belg
. 2016 Sep;
82(2):358-364.
PMID: 27682300
We compare clinical outcomes of two different supplementary tibial fixation in anterior cruciate ligament (ACL) reconstruction using free tendon Achilles allograft. Eighty subjects underwent ACL reconstruction using Endobutton CL for...
4.
Luk A, Li X, Zhang Y, Guo X, Jia W, Li W, et al.
Diabet Med
. 2015 Oct;
33(9):1230-9.
PMID: 26511783
Aims: Diabetic kidney disease independently predicts cardiovascular disease and premature death. We examined the burden of chronic kidney disease (CKD, defined as an estimated GFR < 60 ml/min/1.73 m(2) )...
5.
Lee S, Rhee M, Yang H, Ha H, Lee J, Kwon H, et al.
Diabet Med
. 2015 Jul;
33(5):631-8.
PMID: 26220259
Aim: To determine whether preadipocyte factor 1 could be a predictive marker for the development of diabetes in people without diabetes at baseline. Methods: We conducted a population-based, nested case-control...
6.
Yang H, Lee S, Han K, Kang B, Lee S, Yoon K, et al.
Diabetes Metab
. 2015 Apr;
41(4):282-290.
PMID: 25908414
Aim: This study investigated whether serum zinc concentration is associated with glucose tolerance, insulin resistance and metabolic health status in Korean adults. Methods: Subjects with available serum zinc levels were...
7.
Strojek K, Yoon K, Hruba V, Elze M, Langkilde A, Parikh S
Dtsch Med Wochenschr
. 2013 Mar;
138 Suppl 1:S16-26.
PMID: 23529567
Aims: Progressive deterioration of glycaemic control in type 2 diabetes mellitus (T2DM) often requires treatment intensification. Dapagliflozin increases urinary glucose excretion by selective inhibition of renal sodium-glucose cotransporter 2 (SGLT2)....
8.
Yoon K, Steinberg H, Teng R, Golm G, Lee M, ONeill E, et al.
Diabetes Obes Metab
. 2012 Mar;
14(8):745-52.
PMID: 22405352
Aim: To assess the 54-week efficacy of initial combination therapy with sitagliptin and pioglitazone, compared with pioglitazone monotherapy, and to assess safety in these groups during the 30 weeks after...
9.
Strojek K, Yoon K, Hruba V, Elze M, Langkilde A, Parikh S
Diabetes Obes Metab
. 2011 Jun;
13(10):928-38.
PMID: 21672123
Aims: Progressive deterioration of glycaemic control in type 2 diabetes mellitus (T2DM) often requires treatment intensification. Dapagliflozin increases urinary glucose excretion by selective inhibition of renal sodium-glucose cotransporter 2 (SGLT2)....
10.
Yoon K, Shockey G, Teng R, Golm G, Thakkar P, Meehan A, et al.
Int J Clin Pract
. 2011 Jan;
65(2):154-64.
PMID: 21235696
Aim/hypothesis: To assess the safety and efficacy of initial combination therapy with sitagliptin and pioglitazone compared with pioglitazone monotherapy in drug-naïve patients with type 2 diabetes. Methods: A total of...